Reference : Comment je traite ... une obesite severe et ses anomalies metaboliques par une gastropla...
Scientific journals : Article
Life sciences : Agriculture & agronomy
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/12578
Comment je traite ... une obesite severe et ses anomalies metaboliques par une gastroplastie.
French
[fr] How I treat ... an individual with severe obesity and metabolic abnormalities with gastroplasty
Luyckx, Françoise mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chimie médicale >]
Scheen, André mailto [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Letiexhe, Michel [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Desaive, Claude [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
Gielen, Jean-Louis mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie maxillo-faciale et plastique >]
Lefebvre, Pierre [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
1999
Revue Médicale de Liège
Hopital de Baviere
54
3
138-42
Yes (verified by ORBi)
0370-629X
Liège
Belgique
[en] Cardiovascular Diseases/etiology ; Diabetes Mellitus, Type 2/etiology ; Gastroplasty/methods ; Humans ; Insulin Resistance ; Liver/pathology ; Metabolic Diseases/etiology ; Obesity, Morbid/complications/surgery ; Risk Assessment
[en] Severe obesity, defined as a body mass index > or = 35 kg/m2, is frequently associated with various biological abnormalities, particularly in the presence of intra-abdominal adiposity. The most important disorders belong to the so-called insulin resistance syndrome, metabolic syndrome or syndrome X: hyperinsulinaemia, impaired glucose tolerance or type 2 diabetes, dyslipidaemias, hyperuricaemia, hyperfibrinogenaemia. All these metabolic abnormalities are considered as cardiovascular risk factors. They are also correlated with the severity of the liver steatosis which is commonly observed in individuals with severe obesity. We report our experience of the evolution of these metabolic abnormalities after a marked weight loss induced by gastroplasty. We will analyse the favourable effects of bariatric surgery on insulin sensitivity, biological components of the metabolic syndrome, type 2 diabetes and liver steatosis.
http://hdl.handle.net/2268/12578

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.